Managed Care: Effect of an Academic Detailing Intervention on the Utilization Rate of Cyclooxygenase-2 Inhibitors in the Elderly

Abstract

Spanish

French

Background:

Osteoarthritis is prevalent in the elderly. Nova Scotia general practitioners (GPs) identified the need for an academic detailing (AD) intervention aimed at optimizing the management of osteoarthritis. AD was provided by Dalhousie University Continuing Medical Education in a face-to-face encounter employing evidence-based information. GP participation was voluntary.

Objective:

To evaluate the effect of a GP-targeted osteoarthritis AD intervention on a reduction in the prescribing of cyclooxygenase-2 (COX-2) inhibitors, as well as examine the intervention effect on the utilization rates of gastroprotective agents and medical services.

Methods:

A retrospective cohort study design employing administrative data was used. Differences in utilization rates between intervention and control groups were evaluated using generalized estimating equations analysis for longitudinal data over four 90-day postintervention periods. Confounding was addressed using propensity scores to adjust for between-group bias on the measured covariates.

Results:

The between-group difference for change in COX-2 utilization rates was 0.76 defined daily doses/patient (p = 0.040; 95% CI 0.037 to 1.48) for the 3-month period following the intervention, with lower COX-2 utilization in the AD intervention group than in the control group. The intervention group showed a significant decrease in the within-group utilization rate between the pre- and postintervention periods (z = -2.34; p = 0.019). The between-group difference for change in GP office visit rates was 0.40 visits/patient (p = 0.028; 95% CI 0.046 to 0.79) with the intervention group, showing higher visit rates compared with the control group.

Conclusions:

The osteoarthritis AD intervention was associated with a significant decrease (23%) in COX-2 utilization rates in the 3-month period immediately following the intervention. The only secondary outcome to show a significant between-group effect was the GP office visit rate, which was higher for the intervention group in the second 3-month postintervention period.

Keywords

academic detailing cyclooxygenase-2 inhibitors pharmacoepidemiology prescribing behavior

Get full access to this article

View all access options for this article.

References

Thomson O'brien

, Oxman

, Davis

, Heynes

, Freemantle

, Harvey

. Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2000(2):CD000409.

Grimshaw

, Thomas

, MacLennan

. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 2004;8:1-72.

Bloom

. Effects of continuing medical education on improving physician clinical care and patient health: a review of systematic reviews. Int J Technol Assess Health Care Summer 200521:380-5.

Dalhousie University Continuing Medical Education. http://cme.medicine.dal.ca/ADS.htm (accessed 2007 Dec 3).

Maclure

, Allen

, Bacovsky

. Show me the evidence: best practices for using educational visits to promote evidence-based prescribing. Victoria, BC: Drug Policy Futures, 2006.

Bacovsky

, Maclure

, Nguyen

. Canadian Academic Detailing Collaboration: evaluating processes and outcomes of academic detailing. CPJ 2006;139(Mar/Apr):54-7.

Drug Evaluation Alliance of Nova Scotia. www.gov.ns.ca/health/Pharmacare/industry/deans_academic.asp (accessed 2007 Dec 3).

MacLean

. Quality indicators for the management of osteoarthritis in vulnerable elders. Ann Intern Med 2001;135:711-21.

Lawrence

, Helmick

, Arnett

. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998;41:778-99.

10.

Drug and Therapeutics Information Service. www.uky.edu/UE/CC/diabetes.htm (accessed 2007 Dec 3).

11.

Soumerai

, Avorn

Principles of educational outreach (‘academic detailing’) to improve clinical decision making. JAMA 1990;263:549-56.

12.

Janssens

, De Meyere

, Habraken

. Barriers to academic detailers: a qualitative study in general practice. Eur J Gen Pract 2005;11:59-63.

13.

Allen

, Ferrier

, O'connor

, Fleming

Family physicians' perceptions of academic detailing: a quantitative and qualitative study. BMC Med Educ 2007;7:36. www.biomedcentral.com/1472-6920/7/36 (accessed 2008 Apr 10).

14.

Silverstein

, Faich

, Goldstein

. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 2000;284:1247-55.

15.

Bombardier

, Laine

, Reicin

. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 2000;343:1520-8.

16.

Nova Scotia Department of Health Programs and Services. www.gov.ns.ca/health/Pharmacare/benefitsfaq.asp (accessed 2007 Dec 3).

17.

Cox

, Motheral

, Frisse

, Behm

, Mager

Prescribing COX-2s for patients new to cyclo-oxygenase inhibition therapy. Am J Manag Care 2003;9:735-42.

18.

Dalhousie University Population Health Research Unit. www.phru.dal.ca (accessed 2007 Dec 3).

19.

Canadian Institute for Health Information. Privacy and confidentiality of health information at CMI: principles and policies for the protection of personal health information and policies for institution-identifiable information. 3rd ed. Ottawa: Canadian Institute for Health Information, 2002.

20.

D'Agostino

Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998;17:2265-81.

21.

Drake

, Fisher

Prognostic models and the propensity score. Int J Epidemiol 1995;24:183-7.

22.

Joffe

, Rosenbaum

. Invited commentary: propensity scores. Am J Epidemiol 1999;150:327-33.

23.

Parsons

. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. Presented at: 26th Annual SAS Users Group International Conference, Long Beach, CA, April 22-25, 2001.

24.

Rosenbaum

, Rubin

. Reducing bias in observational studies using subclassification on the propensity score. J Am Statistical Assoc 1984;79:516-24.

25.

Rubin

. Estimating causal effects from large data sets using propensity scores. Ann Intern Med 1997;127:757-63.

26.

Shadish

, Cook

, Campbell

. Experimental and quasi-experimental designs for generalized causal inference. Boston: Houghton Mifflin, 2001.

27.

Sturmer

, Joshi

, Glynn

, Avorn

, Rothman

, Schneeweiss

A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol 2006;59:437-47.

28.

Graham

. Effect of academic detailing on utilization rates of COX-2 inhibitors. Gainesville, FL: University of Florida, 2005. http://purl.fcla.edu/fcla/etd/UFE0011901 (accessed 2008 Apr 11).

29.

World Health Organization Collaborating Center for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment. Geneva, Switzerland: World Health Organization, 2005.

30.

SAS/STAT Software: release 8.2. Cary, NC: SAS Institute Inc.

31.

Graham

, Frail

, Allen

, Sketris

. The Dalhousie academic detailing service: designing an intervention on the topic of osteoarthritis. In: MacKinnon

, ed. Safe and effective: the eight essential elements of an optimal medication-use system. Ottawa, ON: Canadian Pharmacists Association, June 2007.

32.

Roos

, Gupta

, Soodeen

, Jebamani

Data quality in an information-rich environment: Canada as an example. Can J Aging 2005;(spring): 153-69.

33.

Roos

, Mustard

, Nicol

. Registries and administrative data: organization and accuracy. Med Care 1993;31:201-12.